HealthStream Reports Record Q4 Revenue and Raises Dividend

The latest update is out from HealthStream ( (HSTM) ).

HealthStream reported on February 23, 2026 that fourth-quarter 2025 revenue rose 7.4% year over year to a record $79.7 million, driven by higher subscription sales and supported by acquisitions of Virsys12 and MissionCare Collective, though GAAP operating income and net income declined due to a $3.8 million CEO-funded stock grant to more than 700 non-officer employees. For full-year 2025, revenue increased 4.3% to $304.1 million and adjusted profitability improved, while the board approved a share repurchase program and raised the quarterly dividend by 12.9% to $0.035 per share, underscoring continued capital returns to shareholders despite one-time compensation charges and higher operating costs linked to recent growth investments.

The most recent analyst rating on (HSTM) stock is a Hold with a $23.50 price target. To see the full list of analyst forecasts on HealthStream stock, see the HSTM Stock Forecast page.

Spark’s Take on HSTM Stock

According to Spark, TipRanks’ AI Analyst, HSTM is a Neutral.

HealthStream’s overall stock score reflects strong financial performance and positive earnings call highlights, tempered by a bearish technical outlook and high valuation. The company’s strategic acquisitions and strong cash position support future growth prospects.

To see Spark’s full report on HSTM stock, click here.

More about HealthStream

HealthStream, Inc., based in Nashville and listed on Nasdaq under the ticker HSTM, is a healthcare technology platform company focused on clinical workforce solutions. The company generates most of its revenue from subscription-based services and professional offerings that help healthcare organizations manage training, compliance and workforce development needs.

Average Trading Volume: 283,819

Technical Sentiment Signal: Sell

Current Market Cap: $593.4M

Learn more about HSTM stock on TipRanks’ Stock Analysis page.